Penumbra Inc

No reviews yet · Write a Review
Headquartered in Alameda, California, Penumbra, Inc. is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. We have a broad portfolio of products that addresses challenging medical illness and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions that our products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.

Company Details

Address
1351 Harbor Bay Pkwy
Alameda, CA 94502

Competitors of Penumbra Inc

MicroVention continues to lead the way in neuroendovascular therapies through continued introduction of new neuro-interventional products including Access Products, Intraluminal Stents, Occlusion Balloons, and Polymer Coils, and is recognized as a market leader and clinical innovator. Read More

0 Products 0 White Papers 0 Press Releases

Innovators in polymer vascular plugs and coils. Read More

0 Products 0 White Papers 0 Press Releases

Our product, the PneumRx Coil System, (limited by Federal law to investigational use in the U.S.) is designed to help treat severe emphysema. Read More

0 Products 0 White Papers 0 Press Releases

News & Press Releases

View All
Press Release

Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Published: 12/29/2025
Press Release

Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference

Published: 11/19/2025
Press Release

Penumbra, Inc. to Present at Upcoming Investor Conferences_08-20-2025

Published: 8/20/2025
Press Release

Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference

Published: 7/30/2025
Press Release

Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial

Published: 6/16/2025
Press Release

Penumbra, Inc. to Present at Upcoming Investor Conferences

Published: 5/20/2025
Press Release

Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

Published: 4/29/2025
Press Release

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference

Published: 11/20/2024
Press Release

Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke

Published: 10/14/2024